Antihyperlipidemic-eicosapentaenoic acid (EPA) derivatives

The phrase "Antihyperlipidemic-eicosapentaenoic acid (EPA) derivatives" is a compendial classification string rather than an official FDA Established Pharmacologic Class, representing lipid-regulating agents formulated from eicosapentaenoic acid

The phrase "Antihyperlipidemic-eicosapentaenoic acid (EPA) derivatives" is a compendial classification string rather than an official FDA Established Pharmacologic Class, representing lipid-regulating agents formulated from eicosapentaenoic acid

These agents—most notably icosapent ethyl and omega-3 acid ethyl ester mixtures—primarily function by suppressing hepatic very-low-density lipoprotein and triglyceride synthesis while enhancing triglyceride clearance from circulating lipoproteins

These agents—most notably icosapent ethyl and omega-3 acid ethyl ester mixtures—primarily function by suppressing hepatic very-low-density lipoprotein and triglyceride synthesis while enhancing triglyceride clearance from circulating lipoproteins

Therapeutically, they are used as an adjunct to dietary modification to treat severe hypertriglyceridemia and, in purified single-agent form, to lower cardiovascular event risk in select high-risk patients with elevated triglyceride levels